blenrep

Generic: belantamab mafodotin

Labeler: glaxosmithkline llc
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name blenrep
Generic Name belantamab mafodotin
Labeler glaxosmithkline llc
Dosage Form INJECTION, POWDER, FOR SOLUTION
Routes
INTRAVENOUS
Active Ingredients

belantamab mafodotin 50 mg/mL

Manufacturer
GlaxoSmithKline LLC

Identifiers & Regulatory

Product NDC 0173-0913
Product ID 0173-0913_aef7c34c-fef8-407c-99c0-a68aded53c60
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761440
Listing Expiration 2026-12-31
Marketing Start 2025-10-23

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 01730913
Hyphenated Format 0173-0913

Supplemental Identifiers

RxCUI
2725585 2725587
UNII
DB1041CXDG

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name blenrep (source: ndc)
Generic Name belantamab mafodotin (source: ndc)
Application Number BLA761440 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • 50 mg/mL
source: ndc
Packaging
  • 1 VIAL in 1 CARTON (0173-0913-01) / 1.4 mL in 1 VIAL
source: ndc

Packages (1)

0173-0913-01 1 VIAL in 1 CARTON (0173-0913-01) / 1.4 mL in 1 VIAL

Ingredients (1)

belantamab mafodotin (50 mg/mL)

Linked Drug Pages (1)

Blenrep ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "aef7c34c-fef8-407c-99c0-a68aded53c60", "openfda": {"unii": ["DB1041CXDG"], "rxcui": ["2725585", "2725587"], "spl_set_id": ["aef7c34c-fef8-407c-99c0-a68aded53c60"], "manufacturer_name": ["GlaxoSmithKline LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (0173-0913-01)  / 1.4 mL in 1 VIAL", "package_ndc": "0173-0913-01", "marketing_start_date": "20251023"}], "brand_name": "Blenrep", "product_id": "0173-0913_aef7c34c-fef8-407c-99c0-a68aded53c60", "dosage_form": "INJECTION, POWDER, FOR SOLUTION", "product_ndc": "0173-0913", "generic_name": "belantamab mafodotin", "labeler_name": "GlaxoSmithKline LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Blenrep", "active_ingredients": [{"name": "BELANTAMAB MAFODOTIN", "strength": "50 mg/mL"}], "application_number": "BLA761440", "marketing_category": "BLA", "marketing_start_date": "20251023", "listing_expiration_date": "20261231"}